MetLife Investment Management, LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 107 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q2 2018$234,000
+203.9%
41,313
+128.2%
0.00%
+200.0%
Q1 2018$77,000
-67.4%
18,103
-58.9%
0.00%
-66.7%
Q4 2017$236,00044,0630.00%
Other shareholders
ENDOLOGIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$62,127,0007.14%
Essex Woodlands Management, Inc. 1,257,468$24,875,0004.49%
First Light Asset Management, LLC 304,602$4,673,0002.20%
ArrowMark Colorado Holdings LLC 3,464,775$53,150,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,449,897$37,581,0001.25%
Iguana Healthcare Management, LLC 200,000$3,068,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,262,0000.71%
PALISADE CAPITAL MANAGEMENT, LP 1,651,798$25,339,0000.64%
PERKINS CAPITAL MANAGEMENT INC 34,200$525,0000.46%
CADIAN CAPITAL MANAGEMENT, LP 967,443$14,841,0000.44%
View complete list of ENDOLOGIX INC shareholders